secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLIFE SOLUTIONS INC (BLFS)
CIK:        0000834365
Form:       8-K
Filed at:   2022-06-15T23:59:59+00:00
Accession:  0001437749-22-015066
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioLife Solutions stockholders re-elect all directors, approve equity plan increase
--------------------------------------------------------------------------------

- All five nominees re-elected: Michael Rice (26.8M for), Joydeep Goswami (26.5M), Joseph Schick (21.9M), Amy DuRoss (26.0M), Rachel Ellingson (26.3M).
- Non-binding advisory vote on executive compensation approved with 20.1M for, 7.0M against, 127K abstain.
- Ratification of Grant Thornton as independent auditor for FY2022 passed (31.1M for, 10K against, 8K abstain).
- Amendment to 2013 Performance Incentive Plan to increase authorized shares by 2M to 8.5M approved (19.1M for, 8.0M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/834365/000143774922015066/0001437749-22-015066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/834365/000143774922015066/bioli20220614_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-015066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer